Hm Capital Management, LLC Abb Vie Inc. Transaction History

Hm Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $181,868 - $225,647	1,378 New	1,378 $223,000
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $459,704 - $539,541	-5,351 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $392,602 - $525,361	5,351 New	5,351 $525,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hm Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hm Capital Management, LLC with notifications on news.